The World Health Organization (WHO) has recommended that “preparations considered to be pure cannabidiol CBD should not be scheduled within the International Drug Control Conventions,” Hempsupporter reports. The statement was issued following the 40th meeting of the organization’s Expert Committee on Drug Dependence on June 7-8 in Geneva.
Four important excerpts:
- “There are no case reports of abuse or dependence relating to the use of pure CBD.”
- “No public health problems have been associated with CBD use.”
- “CBD has been found to be generally well tolerated with a good safety profile.”
- “There is no evidence that CBD is liable to similar abuse and similar ill-effects as substances…such as cannabis or THC.”
The WHO also considered the cannabis plant; its resin, extracts, and tinctures; and the chemical makeup of THC and its isomers.
Despite the obvious evidence above, the DEA has confirmed CBD’s status as Schedule 1 in recent years and threats of a CBD market crackdown have haunted entrepreneurs around the country. Language in the 2018 Farm Bill, however, seeks to federally legalize hemp and all of its derivatives, including CBD extractions, tinctures, and other potential health products.
Get daily cannabis business news updates. Subscribe